Jeffrey W. Albers - Aug 26, 2021 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
CEO and President, Director
Signature
/s/ Xing Yan, Attorney-in-Fact
Stock symbol
BPMC
Transactions as of
Aug 26, 2021
Transactions value $
$29,920
Form type
4
Date filed
8/30/2021, 04:04 PM
Previous filing
Aug 23, 2021
Next filing
Nov 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Options Exercise $29.9K +16K +9.28% $1.87* 188K Aug 26, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -16K -10.07% $0.00 143K Aug 26, 2021 Common Stock 16K $1.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on July 30, 2014 and is fully vested.